Alpinia blepharocalyx K. SCHUM belongs to the Zingiberaceae family and is widely distributed in the southwest of China including Yunnan and Shichuan provinces and Tibet. The seeds of the plant are used in Chinese traditional medicines for the treatment of stomach disorders. 1) In the course of our studies on antiproliferative natural products, 2) we found that the 95% EtOH extract of the seeds of A. blepharocalyx showed potent antiproliferative activity against human HT-1080 fibrosarcoma cells 3) (ED 50 , 7.3 mg/ml) and highly liver metastatic murine colon 26-L5 carcinoma cells 4) (ED 50 , 33.2 mg/ml). Thus, the extract was separated into hexane, ether and residual fractions, and the latter two fractions were found to show more potent antiproliferative activity than the former fraction; ED 50 values against HT-1080 fibrosarcoma and colon 26-L5 carcinoma cells: hexane fraction, 7.1 and 62.8 mg/ml; ether fraction, 9.0 and 5.0 mg/ml; residual fraction, 12.3 and 6.8 mg/ml, respectively. . [5] [6] [7] Among the novel diarylheptanoids, 1-25 possessed a chalcone or a flavanone moiety at C-5 (calyxin A type) or at C-7 (calyxin B type). Blepharocalyxins (26-30) have two diarylheptanoid units in a molecule and neocalyxins (31, 32) are the oxidative degradation products of diarylheptanoid with a flavanone moiety.
Diarylheptanoids possess interesting biological and pharmacological activities including antioxidant, 8) antiinflammatory, 9) antihepatotoxic, 10) anticancer 11) and antiulcer 12) activities, while, flavonoids are reported to have significant cytotoxic activity.
13) Thus, we have been interested in the biological activity of the novel diarylheptanoids and reported nitric oxide (NO) inhibitory activity of diarylheptanoids obtained from the ether fraction. 14) In this paper, we report the antiproliferative activity of the compounds isolated from the ether and residual fractions against human HT-1080 fibrosarcoma and murine colon 26-L5 carcinoma cells.
MATERIALS AND METHODS

Materials
Compounds 1-57 were isolated from the seeds of A. blepharocalyx. [5] [6] [7] RPMI-1640 medium and Eagle's minimum essential medium (EMEM) were purchased from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan), and sodium bicarbonate and glutamine were from Wako Pure Chemicals Industries, Ltd. (Osaka, Japan). Fetal calf serum was from Gibco BRL Products (Gaithersburg, MD, U.S.A.) and 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide (MTT) was from Sigma Chemicals (St. Louis, MO, U.S.A.). The 96-well cell culture plates were purchased from Falcon, Becton Dickinson (Lincoln Park, NJ, U.S.A.) and 5-fluorouracil was from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan).
Cell Culture Human HT-1080 fibrosarcoma and murine colon 26-L5 carcinoma cells were maintained in EMEM and RPMI-1640 medium, respectively. These media were supplemented with 10% fetal calf serum, 0.1% sodium bicarbonate and 2 mM glutamine.
Antiproliferative Activity Assay Cellular viability in the presence and absence of the experimental agents was determined using the standard MTT assay method 15) as described previously. 16) In brief, the exponentially growing cells were harvested and 100 ml suspension of cell containing 2000 cells was plated in 96-well plates. After 24 h incubation at 37°C under 5% CO 2 to allow cell attachment, the cells were treated with varying concentrations of test samples in their respective medium (100 ml) and incubated again for 72 h under the same conditions. After exposure of the cells to MTT (0.04%, 100 ml) for 3 h, the formazan formed was dissolved in 100 ml dimethyl sulfoxide (DMSO) and the amount was measured spectrophotometrically at 590 nm using a Perkin Elmer HTS-7000 plate reader. The test specimens were dissolved in DMSO and diluted with the respective medium; the final concentration of DMSO was less than 0.25% and the same extent of DMSO was added to the control. 5-Fluorouracil (5-FU) and curcumin were used as positive controls.
RESULTS AND DISCUSSION
The isolated compounds were examined for their antiproliferative activity at different concentrations against the cancer cells and they exhibited various potencies of activity con-centration-dependently (Table 1) . Among them, calyxin B (2), epicalyxin F (17), blepharocalyxin D (29), (3S)-methoxy-1,7-bis(4-hydroxyphenyl)-6E-hepten-5-one (37), (3S,5S)-3,5-dihydroxy-1,7-bis(4-hydroxyphenyl)heptane (45), phloroglucinol (56) and a mixture (1 : 2) of calyxin G (7) and epicalyxin G (18) showed potent antiproliferative activity (ED 50 Ͻ 4 mg/ml) 17) against colon 26-L5 carcinoma cells, while 2, calyxin K (11), 17, epicalyxins I (20) and K (22), 6-hydroxycalyxin F (25), blepharocalyxin B (27) and mixtures of 7 and 18 and of calyxin J (10) and epicalyxin J (21) potently inhibited the proliferation of human HT-1080 fibrosarcoma cells.
The inhibitory activity of a mixture of 7 and 18 against colon 26-L5 carcinoma cells (ED 50 , 0.59 mM) was identical to that of 5-FU (ED 50 , 0.53 mM), a clinically used drug for the treatment of cancers, 18) but that of 7 was weak. Thus, epicalyxin G (18) should be more potent than 5-FU, while the inhibitory activity of the compounds showing the potent activity against human HT-1080 fibrosarcoma cells was stronger than 5-FU (ED 50 , 8.00 mM). Interestingly, a mixture of 10 and 21 exhibited the most potent activity (ED 50 , 0.32 mM). But the activity of 10 was identical to that of 5-FU and thus 21 should have much less ED 50 value than 0.32 mM. However, the presence of both diarylheptanoid and flavonoid moieties is important for this activity, because the novel diarylheptanoids (1-14, 16-32 ) possessed more potent activity than curcumin and other simple diarylheptanoids (33-36, 38-45) . Moreover, the cyclic diarylheptanoids possessed more potent antiproliferative activity than the corresponding acyclic ones (7, 18 vs. 5; 6, 17 vs. 24) .
The relationship between the stereostructures and the antiproliferative activity could not be deduced from the present study. However, it should be noted here that the 7S isomers were more active than the 7R isomers in diarylheptanoids bearing a chalcone moiety (2 vs. 14; 8 vs. 19; 17 vs. 6, 25) . In addition, in the diarylheptanoids having a flavanone moiety, one stereoisomer exhibited more potent activity than the other: against colon 26-L5 carcinoma cell line, 11 was more potent than 22; against HT-1080 fibrosarcoma cell line, 3, 4, and 31 were more potent than 15, 16, and 32, respectively; and against both cell lines, 18 and 21 were more potent than 7 and 10, respectively.
Both chalcones (46, 47) and flavanone (49) showed weak antiproliferative activity against the tested cell lines, but the activity of the former is stronger than the latter. Accordingly, diarylheptanoids with a chalcone moiety exhibited stronger antiproliferative activity than the corresponding diarylheptanoids bearing a flavanone moiety (2 vs. 3, 15; 6 vs. 7, 18; 9 vs. 10, 21; 12 vs. 13, 23; 14 vs. 4, 16; 17 vs. 11, 22; 24 vs. 5). Thus, the conjugated double bond in the chalcone moiety may contribute to the antiproliferative activity. The role of phenolic hydroxyl groups in antiproliferative activity seemed to be substantial due to the fact that compounds 8, 19 and 50 with only one phenolic hydroxyl group exhibited weaker activity than the corresponding compounds 2, 14 and 51 with two phenolic hydroxyl groups. These findings and the fact that some of the diarylheptanoids (1, 2, 6 , 26, 27) showed potent inhibition on NO production 14) may suggest that the antiproliferative activity of the compounds is correlated with their antioxidative activity including NO inhibition. This was also supported by similar observation on other compounds.
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